Concord Biotech Limited

Offer PeriodAug 04, 2023 – Aug 08, 2023

MainBoardListed

Listed Price

₹900.05

+21.46%

Price Band₹705 - ₹741

Lot Size20 Shares

Allotment DateAug 14, 2023

Listing DateAug 18, 2023

Subscription26.13 Times

Issue Size₹1551.00 Cr

Check Allotment

Share IPO Trend

IPO Details

Subscription

Lot Distribution

Reservation

Company Fin.

₹125
(16.87%)

Premium (ELP)

Concord Biotech Limited's achieved publicly listed status following its IPO debut on Aug 18, 2023 at the NSE, BSE platform. The offering successfully mobilized 2,09,25,652 Shares, with TBD allocated to corporate growth initiatives and ₹1551.00 Cr providing liquidity to existing shareholders.

Investment participation occurred within the established price band of ₹705 to ₹741, starting from minimum lots of 20 shares. The subscription window from Aug 04, 2023 through Aug 08, 2023 enabled investor participation across market segments.

Share allocation was completed on Aug 14, 2023, determining ownership distribution among successful applicants. The listing represents a milestone achievement, transitioning the company to regulated public market status with associated responsibilities and opportunities.

Concord Biotech IPO Details

IPO Date

Aug 04, 2023 to Aug 08, 2023

Allotment Date

Aug 14, 2023

List Date

Aug 18, 2023

Lot Size

20 share

Issue Price

₹705 - ₹741

Issue Size

2,09,25,652 (aggregating up to 1551.00 Cr)

Fresh Issue

Offer For Sale

2,09,25,652 (aggregating up to 1551.00 Cr)

Listing At

NSE, BSE

Share Holding Pre-Issue

Share Holding Post-Issue

10,46,16,204

Market Marker Portion

Lot(s) Distribution

Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.

Category	Lot(s)	Qty	Amount

Category	Lot(s)	Qty	Amount
Retail (Min)	1	20	14,820
sHNI	14	280	2,07,480
bHNI	68	1360	10,07,760

IPO Reservation

Shares2,09,25,652

QIB

49.98%(1,04,57,825)

NII (HNI)

14.99%(31,37,348)

RETAIL

34.98%(73,20,479)

Employee

0.05%(10,000)

Total

100.00%(2,09,25,652)

Concord Biotech IPO Key Performance Indicators

KPI	Values

KPI	Values
EPS	20.79
ROE	20.06
ROCE	24.27
RONW	20
PRE IPO(PE)	32.29
POST IPO(PE)	0

Company Financials ( In Crores)

Period Ended	31 Mar 2021	31 Mar 2022	31 Mar 2023

Period Ended	31 Mar 2021	31 Mar 2022	31 Mar 2023
Assets	1,182.55	1,312.80	1,513.98
Revenue	630.75	736.35	888.48
Net Worth	999.37	1,103.22	1,290.00
Total borrowing	86.35	60.59	31.24
Profit after tax	234.89	174.93	240.08
Reserves and Surpluses	0	0	0

Concord Biotech IPO About Company

Incorporated in 1984, Concord Biotech Limited is an India-based biopharmaceutical company and a leading global developer and manufacturer of fermentation-based APIs, specializing in immunosuppressants and oncology. The company has a strong global presence, supplying products to over 70 countries including the USA, India, Europe, and Japan. Concord Biotech manufactures Active Pharmaceutical Ingredients (APIs) through fermentation and semi-synthetic processes, along with finished formulations. Starting with a single product, the company has expanded to offer a broad spectrum of biopharma solutions, establishing itself as a key player in the global API market.

Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."

✅Concord Biotech IPO Strength Factors

⚠️Concord Biotech IPO Risk Factors

🏦Concord Biotech IPO Lead Manager(s)

Kotak Mahindra Capital Company LimitedCitigroup Global Markets India Private LimitedJefferies India Private Limited

👤Concord Biotech IPO Promoter(s)

Mr. Sudhir Vaid
Mr. Ankur Vaid

🏢Concord Biotech IPO Company Details

Concord Biotech Limited

Email:complianceofficer@concordbiotech.com

Phone:079-6813 8700

Website:http://www.concordbiotech.com/

address:1482-86, Trasad Road Dholka, Ahmedabad – 382225

📋Concord Biotech IPO Registrar

Link Intime India Private Limited

Name:Link Intime India Private Limited

Phone:+91-22-4918 6270

Email:concordbiotech.ipo@linkintime.co.in

Website:https://linkintime.co.in/mipo/ipoallotment.html

❓Concord Biotech IPO FAQs

Concord Biotech IPO is a main-board IPO of 0 equity shares of the face value of ₹1 Per Share aggregating up to ₹1551.00 crore shares. The issue is priced at ₹705 - ₹741 per share. The minimum order quantity is .The IPO opens on Aug 04, 2023, and closes on Aug 08, 2023. Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE, BSE.

Zerodha customers can apply online in Concord Biotech IPO using UPI as a payment gateway. Zerodha customers can apply in Concord Biotech IPO by login into Zerodha Console (back office) and submitting an IPO application form. Steps to apply in Concord Biotech IPO through Zerodha (1) Visit the Zerodha website and login to Console. (2) Go to Portfolio and click the IPOs link. (3) Go to the 'Concord Biotech IPO' row and click the 'Bid' button. (4) Enter your UPI ID, Quantity, and Price. (5) Submit IPO application form. (6) Visit the UPI App (net banking or BHIM) to approve the mandate. Visit Zerodha IPO Application Process Review for more detail.

The Concord Biotech IPO opens on Aug 04, 2023 and closes on Aug 08, 2023.

You can apply in Concord Biotech IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.

The finalization of Basis of Allotment for Concord Biotech IPO will be done on Aug 14, 2023, and the allotted shares will be credited to your demat account by Aug 14, 2023

Concord Biotech IPO's listing date is Aug 18, 2023.

Concord Biotech Limited

IPO Details

Subscription

Lot Distribution

Reservation

Company Fin.

₹125(16.87%)

Premium (ELP)

₹125
(16.87%)